Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?-Reference-Cited by-同舟云学术

Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?

Published:2003-03 Issue:3 Volume:14 Page:406-413
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bonnefoi H.,Diebold-Berger S.,Therasse P.,Hamilton A.,van de Vijver M.,MacGrogan G.,Shepherd L.,Amaral N.,Duval C.,Drijkoningen R.,Larsimont D.,Piccart M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/14/3/406/556147/mdg108.pdf

Reference37 articles.

1. The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells;Pegram;Oncogene,1997

2. When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer;Yamauchi;J Clin Oncol,2001

3. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents;Lowe;Cell,1993

4. p53 status and the efficacy of cancer therapy in vivo;Lowe;Science,1994

5. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients;Aas;Nature Med,1996

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Common hotspots of cancer chemotherapy;Genome Instability & Disease;2023-06-13

2. Locally advanced breast cancer arising in the axilla;Journal of Surgical Case Reports;2022-09-01

3. Locally Advanced Breast Cancer: Treatment Patterns and Predictors of Survival in a Saudi Tertiary Center;Cureus;2021-06-08

4. Staging for Breast Cancer With Internal Mammary Lymph Nodes Metastasis: Utility of Incorporating Biologic Factors;Frontiers in Oncology;2021-01-14

5. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis;Technology in Cancer Research & Treatment;2021-01-01